πŸ‡ΊπŸ‡Έ FDA
Patent

US 8026350

Tumor suppressor gene, p28ING5

granted A61PA61P35/00

Quick answer

US patent 8026350 (Tumor suppressor gene, p28ING5) held by The United States of America as represented by theDepartment of Health and Human Services expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by theDepartment of Health and Human Services
Grant date
Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00